Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension

Overview of attention for article published in Circulation, June 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 6 X users
patent: 21 patents

facebook: 1 Facebook page

Readers on

mendeley: 93 Mendeley

So far, Altmetric has seen 21 patents that reference this research output.

METHODS OF TREATING PAH WITH COMBINATIONS OF RALINEPAG AND OTHER AGENTS

Application EP-4681708-A2

European Patent Office

21 Jan 2026

Methods of treating PAH with combinations of ralinepag and other agents

Grant US-12377067-B2

United States of America

05 Aug 2025

Compounds

Grant US-12180210-B2

United States of America

31 Dec 2024

Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors

Grant US-10647727-B2

United States of America

12 May 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 17 additional patents.